Sigmaroc Shares Outstanding History (SRC)
Sigmaroc reported 1.10B shares outstanding at the end of fiscal 2025.
View full Sigmaroc company overviewSigmaroc annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.10B | 12.3M | +1.13% |
| 2024 | 2024-12-31 | 1.09B | 391.5M | +56.43% |
| 2023 | 2023-12-31 | 693.8M | 55.6M | +8.70% |
| 2022 | 2022-12-31 | 638.2M | — | — |
Sigmaroc quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 1.10B | 12.3M | +1.13% |
| Q4 2024 | 2024-12-31 | 1.09B | — | — |
Sigmaroc shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Sigmaroc's shares outstanding moved from 638.2M to 1.10B, a change of 459.4M. The latest reported quarter, Q4 2025, shows 1.10B.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
reported period-end shares
TickerStat displays period-end common shares from official filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sigmaroc source filings ↗Community posts
SigmaRoc: H1 margins improve as the group agrees the Dolomitas acquisition
SigmaRoc released half-year results and an acquisition announcement on 7 September 2026. H1 performance Measure H1 2026 H1 2025 Revenue £523.1m £510.3m Underlying EBITDA £131.2m £117.8m Underlying EBITDA margin 25.1% 23.1% Statutory pretax ...